Some studies have shown that NOX1 and its transmembrane subunit P22phox and NOX5 are overexpressed in prostate cancer [99–102], and downregulated NOX5 expression can inhibit cell proliferation and tumor growth and induce apoptosis of prostate cancer cells [103]. This evidence concerns the gene NOX5 and prostate cancer.